Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Emerging research with immune checkpoint inhibitors in basal cell carcinoma (BCC)
Date
22 Sep 2020Session
Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancerPresenters
Susana PuigAuthors
S. PuigAuthor affiliations
- Melanoma Unit, Dermatology Department, Hospital Clinic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Barcelona/ES
Resources
Resources from the same session
Exploring the emerging research with immuno-oncology in CSCC
Presenter: Dirk Schadendorf
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast
Welcome introduction and objectives and Treatment for locally advanced/metastatic cutaneous squamous cell carcinoma (CSCC)
Presenter: Chrysalyne Schmults
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast